ID   Mel249
AC   CVCL_3974
SY   MEL249
DR   BTO; BTO_0002952
DR   Wikidata; Q54905162
RX   PubMed=16740750;
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Asn62Argfs (c.184_185delAT); Zygosity=Unspecified (PubMed=16740750).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
RX   PubMed=16740750; DOI=10.1158/1078-0432.CCR-05-2174;
RA   Paschen A., Arens N., Sucker A., Greulich-Bode K.M., Fonsatti E.,
RA   Gloghini A., Striegel S., Schwinn N., Carbone A., Hildenbrand R.,
RA   Cerwenka A., Maio M., Schadendorf D.;
RT   "The coincidence of chromosome 15 aberrations and beta2-microglobulin
RT   gene mutations is causative for the total loss of human leukocyte
RT   antigen class I expression in melanoma.";
RL   Clin. Cancer Res. 12:3297-3305(2006).
//